Eucalyptus

Eucalyptus is an Australian telemedicine platform that connects patients with healthcare practitioners, providing asynchronous consultations to diagnose and provide treatments. The company operates a direct-to-consumer business model, offering a range of virtual care services via five healthcare-related portals that cover men’s health, fertility care, sexual health, skincare, and menopause. 

Patients begin by filling out an online questionnaire before being contacted by a licensed healthcare practitioner for a text-based consultation. Prescriptions are fulfilled through third-party pharmacies and are delivered by mail. It also operates an online store, where users can purchase non-prescription products. 

As of July 2024, the company operated five telehealth clinics: men’s health platform Pilot, a holistic women’s health platform Juniper, teledermatology brand Software, fertility health service Kin, and men’s preventive healthcare platform Compound.

The company planned to expand into the UK in January 2022, following the company raising USD 42 million. 

The company expanded its operations into Japan in October 2023, initially making its platform Juniper available to users in Japan with a focus on its weight loss-related services. 

The company operated on a D2C basis, charging users on a per consultation basis. The company noted that, as of June 2024, on average, users could expect to pay AUD 20 (USD 13.1) in out-of-pocket expenses per consultation.

Key customers and partnerships

Since its launch in 2019, Eucalyptus had provided 700,000 consultations as of June 2024 and claimed to be the largest vertically integrated telehealth platform in Australia.